FDA Inspection 1014205 — Gulf Coast Regional Blood Center At Westchase

Gulf Coast Regional Blood Center At Westchase — FEI 3006799214

The FDA completed an inspection of Gulf Coast Regional Blood Center At Westchase on Feb 7, 2017 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Feb 7, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Houston, TX (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.